2002 (3) TMI 452 - AT - Central Excise

Summary

The Appellate Tribunal CEGAT, Mumbai dismissed the appeal by Glenmark Pharmaceuticals Ltd. The Commissioner (Appeals) held that the medicament manufactured by Glenmark did not become a patent or proprietary medicament as it bore the manufacturer's name in bold letters. The Tribunal upheld the Commissioner's decision, citing the Supreme Court's judgment in Astra Pharmaceuticals (P) Ltd. v. CCE.